Navigation Links
U of M scientist gets 5-year, $10 million grant to direct innovative HIV research program

Reuben Harris, professor in the University of Minnesota's College of Biological Sciences, has been awarded a five-year, $10 million grant from the National Institutes of Health to direct a large-scale research effort to study a human antiviral protein with potential for treating HIV and other viral diseases.

The goal of the study will be to produce atomic resolution images of the protein (APOBEC3G) to better understand how it interacts with other proteins in human cells and with HIV to prevent the virus from attaching to and entering cells. This fundamental knowledge could lead to novel methods to alter this protein to make it more effective.

"You have to understand the nuts and bolts of the system before you can make alterations to interfere with the process," says Harris, an associate professor of biochemistry, molecular biology and biophysics. "I'm very optimistic that this will research will enable us to use this novel protein against HIV and other diseases."

The approach represents a paradigm shift in treating viral diseases. While most other strategies focus on the virus itself, this is among the first to focus on the host.

"Conventional methods focusing on HIV are susceptible to the inevitable emergence of drug resistant virus isolates, whereas drugs that target stable cellular proteins may be much less prone to this problem" says Harris.

Human cells produce a family of antiviral proteins (called APOBECs) that have the ability to destroy HIV. But HIV has evolved a way to overcome them using an accessory protein called Vif (virion infectivity factor) to degrade the APOBEC proteins and allow the virus to spread. In a previous study, researchers in Harris's lab showed how HIV binds to and destroys one of the APOBEC proteins. This suggests that a simple change in the chemical structure of the APOBEC proteins could convert the human proteins to more effective antiviral agents. A better understanding of the interaction at molecular and atomic levels is needed to move in that direction.

Harris will lead five teams with complementary skills in molecular virology, NMR spectroscopy, X-ray crystallography, biophysics and biochemistry. Matsuo Hiroshi, associate professor in the College of Biological Sciences, is also a project leader, and Joachim Mueller, associate professor in the College of Science and Engineering's Department of Physics, is a key interdepartmental collaborator. Other sites include the University of Massachusetts Medical School, University of Nebraska and Hebrew University in Israel. Funded by the National Institute of General Medical Sciences, this Program Project grant will support training opportunities for students while advancing research. About half of the projected full amount of the $10 million grant will remain at the University of Minnesota.


Contact: Jeff Falk
University of Minnesota

Related biology news :

1. NIH scientists identify gene that could hold the key to muscle repair
2. Gladstone scientists identify genes involved in embryonic heart development
3. Scripps Research scientists identify mechanism of long-term memory
4. Sackler Prize awarded to pioneering neuroscientist
5. Scientists identify a surprising new source of cancer stem cells
6. Scripps Research scientists uncover new DNA role in modifying gene function
7. Outsmarting cancer cells: SLU scientists learn how they spread
8. Scripps Research scientists find dual switch regulates fat formation
9. Scientists make bamboo tools to test theory explaining East Asias Stone Age tool scarcity
10. Young scientist at Virginia Commonwealth University wins Avanti prize
11. Scientists exploit ash tree pests chemical communication
Post Your Comments:
(Date:5/12/2016)... 2016 , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
Breaking Biology Technology: